Bachem Holding AG
OTC: BCHMF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Anne-Kathrin Stoller
- Employees
- 2,207
- Headquarters
- Bubendorf, Switzerland
- IPO year
- 2011
- Market cap
- $6.5B
- Website
- https://www.bachem.com
Loading BCHMF…
Loading profile data…Frequently asked questions about BCHMF
What does Bachem Holding AG (BCHMF) do?
Bachem Holding AG is a global partner to pharmaceutical and biotechnology companies, supplying crucial products and services for every stage from early-stage research and clinical trials to full-scale commercialization. The company specializes in the creation, manufacturing, and regulatory assistance for peptide active pharmaceutical ingredients...
Where does BCHMF trade?
Bachem Holding AG (BCHMF) trades on the Other OTC.
What sector is BCHMF in?
Bachem Holding AG (BCHMF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Bachem Holding AG?
Anne-Kathrin Stoller is the chief executive officer of Bachem Holding AG (BCHMF).
Where is Bachem Holding AG headquartered?
Bachem Holding AG is headquartered in Switzerland.
Does BCHMF pay a dividend?
Yes — Bachem Holding AG (BCHMF) paid a trailing twelve-month dividend of USD 0.58 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BCHMF go public?
Bachem Holding AG (BCHMF) completed its initial public offering in 2011.